Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aicardi-Goutières Syndrome”

7 trials

Showing 7 of 7 results

Not applicableStudy completedNCT06898372
What this trial is testing

Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome

Who this might be right for
Aicardi-Goutières Syndrome (AGS)
IRCCS Fondazione Stella Maris 24
Not applicableApproved For MarketingNCT01724580
What this trial is testing

Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes

Who this might be right for
Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE)Juvenile Dermatomyositis (JDM)Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI)+1 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT04731103
What this trial is testing

Inhibition of Reverse Transcription in Aicardi-Goutières Syndrome

Who this might be right for
Aicardi-Goutières Syndrome
University of Edinburgh 13
Testing effectiveness (Phase 2)Study completedNCT02363452
What this trial is testing

Reverse Transcriptase Inhibitors in AGS

Who this might be right for
Aicardi-Goutières Syndrome (AGS)
Assistance Publique - Hôpitaux de Paris 11
Testing effectiveness (Phase 2)WithdrawnNCT03304717
What this trial is testing

Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome

Who this might be right for
Aicardi Goutières Syndrome
Children's Hospital of Philadelphia
Testing effectiveness (Phase 2)Active Not RecruitingNCT05613868
What this trial is testing

TPN-101 in Aicardi-Goutières Syndrome (AGS)

Who this might be right for
Aicardi-Goutières Syndrome (AGS)
Transposon Therapeutics, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT03921554
What this trial is testing

JAK Inhibitor Treatment in AGS

Who this might be right for
Aicardi Goutieres Syndrome
Adeline Vanderver, MD 54

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation